INDEPTH Network
  • Contact Us
  • Login


    • Central Data Catalog

    Citations

    Sort results by Author(s) Date Title
    1 Aponte, John J, Pedro Aide, Montse Renom, Inacio Mandomando, Quique Bassat, Jahit Sacarlal, M Nelia Manaca, Sarah Lafuente, Arnoldo Barbosa, Amanda Leach, Marc Lievens, Johan Vekemans, Betuel Sigauque, Marie-Claude Dubois, Marie-Ange Demoitié, Marla Sillman, Barbara Savarese, John G McNeil, Eusebio Macete, W Ripley Ballou, Joe Cohen, and Pedro L Alonso. "Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial." Lancet 370, no. 9598 (2007): 1543-1551.
    2 Asante, Kwaku Poku, Salim Abdulla, Selidji Agnandji, John Lyimo, Johan Vekemans, Solange Soulanoudjingar, Ruth Owusu, Mwanajaa Shomari, Amanda Leach, Erik Jongert, Nahya Salim, Jose F. Fernandes, David Dosoo, Maria Chikawe, Saadou Issifou, Kingsley Osei-Kwakye, Marc Lievens, Maria Paricek, Tina Möller, Stephen Apanga, Grace Mwangoka, Marie-Claude Dubois, Tigani Madi, Evans Kwara, Rose Minja, Aurore B. Hounkpatin, Owusu Boahen, Kingsley Kayan, George Adjei, Daniel Chandramohan, Terrell Carter, Preeti Vansadia, Marla Sillman, Barbara Savarese, Christian Loucq, Didier Lapierre, Brian Greenwood, Joe Cohen, Peter Kremsner, Seth Owusu-Agyei, Marcel Tanner, and Bertrand Lell. "Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial." Lancet Infect Dis (2011).
    3 Kofoed, Poul-Erik, Johan Ursing, Anja Poulsen, Amabelia Rodrigues, Yngve Bergquist, Peter Aaby, and Lars Rombo. "Different doses of amodiaquine and chloroquine for treatment of uncomplicated malaria in children in Guinea-Bissau: implications for future treatment recommendations." Trans. R. Soc. Trop. Med. Hyg. 101, no. 3 (2007): 231-238.
    4 Kofoed, Poul-Erik, Johan Ursing, Amabelia Rodrigues, and Lars Rombo. "Failures following initial treatment for uncomplicated malaria: Quinine as second line therapy." (2007).
    5 Kofoed, Poul-Erik, Johan Ursing, Amabelia Rodrigues, and Lars Rombo. "Paracetamol versus placebo in treatment of non-severe malaria in children in Guinea-Bissau: a randomized controlled trial." Malar. J. (2011).
    6 Leach, Amanda, Johan Vekemans, Marc Lievens, Opokua Ofori-Anyinam, Conor Cahill, Seth Owusu-Agyei, Salim Abdulla, Eusebio Macete, Patricia Njuguna, Barbara Savarese, Christian Loucq, W. Ripley Ballou, and Committee Clinical Trials Partnership. "Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa." Malar. J. (2011).
    7 Ota, Martin O C, Johan Vekemans, Susanna E Schlegel-Haueter, Katherine Fielding, Mariama Sanneh, Michael Kidd, Melanie J Newport, Peter Aaby, Hilton Whittle, Paul-Henri Lambert, Keith P W J McAdam, Claire-Anne Siegrist, and Arnaud Marchant. "Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination." J. Immunol. 168, no. 2 (2002): 919-925.
    8 Sacarlal, Jahit, Pedro Aide, John J Aponte, Montse Renom, Amanda Leach, Inácio Mandomando, Marc Lievens, Quique Bassat, Sarah Lafuente, Eusébio Macete, Johan Vekemans, Caterina Guinovart, Betuel Sigaúque, Marla Sillman, Jessica Milman, Marie-Claude Dubois, Marie-Ange Demoitié, Joelle Thonnard, Clara Menéndez, W Ripley Ballou, Joe Cohen, and Pedro L Alonso. "Long-term safety and efficacy of the RTS,S/AS02A malaria vaccine in Mozambican children." J. Infect. Dis. 200, no. 3 (2009): 329-336.
    9 Swysen, Christine, Johan Vekemans, Myriam Bruls, Sunny Oyakhirome, Chris Drakeley, Peter Kremsner, Brian Greenwood, Opokua Ofori-Anyinam, Brenda Okech, Tonya Villafana, Terrell Carter, Barbara Savarese, Adriano Duse, Andrea Reijman, Charlotte Ingram, John Frean, Bernhards Ogutu, and Committee Clinical Trials Partnership. "Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine." Malar. J. (2011).
    10 Swysen, Christine, Johan Vekemans, Myriam Bruls, Sunny Oyakhirome, Chris Drakeley, Peter Kremsner, Brian Greenwood, Opokua Ofori-Anyinam, Brenda Okech, Tonya Villafana, Terrell Carter, Barbara Savarese, Adriano Duse, Andrea Reijman, Charlotte Ingram, John Frean, and Bernhards Ogutu. "Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine." Malar. J. (2011).
    11 Ursing, Johan, Poul-Erik Kofoed, Amabelia Rodrigues, Yngve Bergqvist, and Lars Rombo. "Chloroquine is grossly overdosed and overused but well tolerated in Guinea-bissau." Antimicrob. Agents Chemother. 53, no. 1 (2009): 180-185.
    12 Ursing, Johan, Poul-Erik Kofoed, Amabelia Rodrigues, Daniel Blessborn, Rikke Thoft-Nielsen, Anders Björkman, and Lars Rombo. "Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial." J. Infect. Dis. 203, no. 1 (2011): 109-116.
    13 Ursing, Johan, Poul-Erik Kofoed, Amabelia Rodrigues, and Lars Rombo. "No seasonal accumulation of resistant P. falciparum when high-dose chloroquine is used." PLoS ONE 4, no. 8 (2009).
    14 Ursing, Johan, Poul-Erik Kofoed, Amabelia Rodrigues, Lars Rombo, and José Pedro Gil. "Plasmodium falciparum genotypes associated with chloroquine and amodiaquine resistance in Guinea-Bissau." Am. J. Trop. Med. Hyg. 76, no. 5 (2007): 844-848.
    15 Ursing, Johan, Poul-Erik Kofoed, Lars Rombo, and J Pedro Gil. "No pfmdr1 amplifications in samples from Guinea-Bissau and Liberia collected between 1981 and 2004." J. Infect. Dis. 194, no. 5 (2006): 716-718; .
    16 Ursing, Johan, Lars Rombo, Poul-Erik Kofoed, and José P Gil. "Carriers, channels and chloroquine efficacy in Guinea-Bissau." Trends Parasitol. 24, no. 2 (2008): 49-51.
    17 Ursing, Johan, Berit Aydin Schmidt, Marianne Lebbad, Poul-Erik Kofoed, Fransisco Dias, José Pedro Gil, and Lars Rombo. "Chloroquine resistant P. falciparum prevalence is low and unchanged between 1990 and 2005 in Guinea-Bissau: an effect of high chloroquine dosage?." Infect. Genet. Evol. 7, no. 5 (2007): 555-561.
    18 Vekemans, Johan, Kevin Marsh, Brian Greenwood, Amanda Leach, William Kabore, Solange Soulanoudjingar, Kwaku Poku Asante, Daniel Ansong, Jennifer Evans, Jahit Sacarlal, Philip Bejon, Portia Kamthunzi, Nahya Salim, Patricia Njuguna, Mary J Hamel, Walter Otieno, Samwel Gesase, and David Schellenberg. "Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care." Malar. J. (2011).
    19 Vekemans, Johan, Kevin Marsh, Brian Greenwood, Amanda Leach, William Kabore, Solange Soulanoudjingar, Kwaku Poku Asante, Daniel Ansong, Jennifer Evans, Jahit Sacarlal, Philip Bejon, Portia Kamthunzi, Nahya Salim, Patricia Njuguna, Mary J. Hamel, Walter Otieno, Samwel Gesase, David Schellenberg, and Committee Clinical Trials Partnership. "Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care." Malar. J. (2011).